Intermittent Preventive Treatment for Malaria in Infants in Navrongo Ghana

• Status: Completed
• Trial end date: 2004-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Evaluation of the safety and effectiveness of malaria intermittent chemotherapy and iron supplementation delivered through Expanded Programme on Immunisation vaccination clinics.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Gates Malaria Partnership; London School of Hygiene and Tropical Medicine
• Collaborators: Department for International Development, United Kingdom; INDEPTH Network; Kintampo Health Research Centre, Ghana; London School of Hygiene and Tropical Medicine; Navrongo Health Research Centre, Navrongo, Ghana.
• Treatments: Fanasil, pyrimethamine drug combination; Pyrimethamine; Sulfadoxine

Criteria

Inclusion Criteria:

• All infants living in study clusters without a history of allergy to sulfadoxine-pyrimethamine were eligible for enrollment in the study.

Exclusion Criteria:

• History of allergy to sulfadoxine-pyrimethamine.